Zdrowie i gospodarka · 22/03/2010

FDA Requests Public Comment on Proposed Collection of Information for Hypertension Indication: Drug Labeling for Cardiovascular Outcome Claims

The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to the guidance on drug labeling for cardiovascular outcome claims for drugs treating hypertension, as required by the Paperwork Reduction Act of 1995.